2021 Q4 Form 10-K Financial Statement

#000143774922007512 Filed on March 29, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $142.0K $564.0K $140.0K
YoY Change 1.43% 4.25% 26.13%
Cost Of Revenue $0.00
YoY Change
Gross Profit $564.0K
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin $3.843M $17.65M $2.310M
YoY Change 66.36% 48.34% -21.96%
% of Gross Profit 3129.96%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $110.0K $423.0K $100.0K
YoY Change 10.0% 11.02% 42.86%
% of Gross Profit 75.0%
Operating Expenses $3.953M $18.08M $2.410M
YoY Change 64.02% 46.96% -20.2%
Operating Profit -$17.51M
YoY Change 48.99%
Interest Expense -$1.986M $11.39M -$4.350M
YoY Change -54.34% -1.21% 5.33%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$5.797M -$30.30M -$6.620M
YoY Change -12.43% -14.99% -5.97%
Income Tax $5.000K $10.00K $0.00
% Of Pretax Income
Net Earnings -$5.904M -$31.20M -$8.020M
YoY Change -26.38% -17.46% 9.12%
Net Earnings / Revenue -4157.75% -5531.91% -5728.57%
Basic Earnings Per Share -$0.84
Diluted Earnings Per Share -$136.0K -$770.4K -$253.5K
COMMON SHARES
Basic Shares Outstanding 43.66M 35.54M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.97M $10.97M $7.300M
YoY Change 50.21% 50.21% -53.5%
Cash & Equivalents $10.97M $10.97M $7.290M
Short-Term Investments
Other Short-Term Assets $1.979M $1.979M $700.0K
YoY Change 182.71% 182.71% 75.0%
Inventory $0.00
Prepaid Expenses
Receivables $270.0K $270.0K $55.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $13.21M $13.21M $8.036M
YoY Change 64.44% 65.18% -50.14%
LONG-TERM ASSETS
Property, Plant & Equipment $78.89M $82.17M $53.48M
YoY Change 47.51% 53.59% 7.08%
Goodwill $3.813M $3.813M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $976.0K $976.0K $1.354M
YoY Change -27.92% -30.29% 85.73%
Other Assets $4.296M $12.32M $4.530M
YoY Change -5.17% 59.99% 10.0%
Total Long-Term Assets $99.28M $99.28M $66.33M
YoY Change 49.68% 49.52% 9.44%
TOTAL ASSETS
Total Short-Term Assets $13.21M $13.21M $8.036M
Total Long-Term Assets $99.28M $99.28M $66.33M
Total Assets $112.5M $112.5M $74.36M
YoY Change 51.28% 51.2% -3.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $286.0K $286.0K $548.0K
YoY Change -47.81% -42.8% 182.47%
Accrued Expenses $808.0K $832.0K $674.0K
YoY Change 19.88% 18.86% -85.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $107.0K $107.0K $51.00K
YoY Change 109.8% 7.0% 64.52%
Total Short-Term Liabilities $2.513M $2.513M $3.135M
YoY Change -19.84% -18.94% -34.76%
LONG-TERM LIABILITIES
Long-Term Debt $46.48M $46.48M $78.60M
YoY Change -40.87% -40.87% -42.87%
Other Long-Term Liabilities $32.00K $22.89M $0.00
YoY Change 27.9% -100.0%
Total Long-Term Liabilities $46.51M $69.37M $78.60M
YoY Change -40.83% -28.11% -42.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.513M $2.513M $3.135M
Total Long-Term Liabilities $46.51M $69.37M $78.60M
Total Liabilities $71.88M $71.88M $99.66M
YoY Change -27.87% -27.9% -37.26%
SHAREHOLDERS EQUITY
Retained Earnings -$573.4M -$539.4M
YoY Change 6.3% 7.54%
Common Stock $436.0K $368.0K
YoY Change 18.48% 29.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $40.61M $40.61M -$25.30M
YoY Change
Total Liabilities & Shareholders Equity $112.5M $112.5M $74.36M
YoY Change 51.28% 51.2% -3.08%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$5.904M -$31.20M -$8.020M
YoY Change -26.38% -17.46% 9.12%
Depreciation, Depletion And Amortization $110.0K $423.0K $100.0K
YoY Change 10.0% 11.02% 42.86%
Cash From Operating Activities -$5.631M -$15.30M -$3.130M
YoY Change 79.9% 13.94% 3.99%
INVESTING ACTIVITIES
Capital Expenditures -$1.814M $22.91M -$630.0K
YoY Change 187.94% 299.86% 270.59%
Acquisitions
YoY Change
Other Investing Activities -$129.0K -$564.0K -$1.400M
YoY Change -90.79% -86.28% 55.56%
Cash From Investing Activities -$1.943M -$23.47M -$2.030M
YoY Change -4.29% 138.59% 89.72%
FINANCING ACTIVITIES
Cash Dividend Paid $1.449M
YoY Change
Common Stock Issuance & Retirement, Net $32.46M
YoY Change 119.81%
Debt Paid & Issued, Net $77.60M
YoY Change 180353.49%
Cash From Financing Activities -1.485M $51.18M 4.940M
YoY Change -130.06% 244.08% 10.02%
NET CHANGE
Cash From Operating Activities -5.631M -$15.30M -3.130M
Cash From Investing Activities -1.943M -$23.47M -2.030M
Cash From Financing Activities -1.485M $51.18M 4.940M
Net Change In Cash -9.059M $12.43M -220.0K
YoY Change 4017.73% -248.14% -153.66%
FREE CASH FLOW
Cash From Operating Activities -$5.631M -$15.30M -$3.130M
Capital Expenditures -$1.814M $22.91M -$630.0K
Free Cash Flow -$3.817M -$38.21M -$2.500M
YoY Change 52.68% 99.45% -11.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Auditor Location
AuditorLocation
Los Angeles, California
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
329
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
329
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 pure
CY2021 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08857 pure
CY2021 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
1190
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0 USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43656169
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36902361
CY2013Q1 cdzi Number Of Milestones For Common Stock Issuance
NumberOfMilestonesForCommonStockIssuance
2 pure
CY2013Q1 cdzi Shares Payable Term From Date Earned
SharesPayableTermFromDateEarned
P3Y
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021 us-gaap Revenues
Revenues
564000 USD
CY2020 us-gaap Revenues
Revenues
541000 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17653000 USD
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
7531
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
7531
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43656169
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43656169
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36902361
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36902361
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11914000 USD
CY2021 us-gaap Depreciation Nonproduction
DepreciationNonproduction
423000 USD
CY2020 us-gaap Depreciation Nonproduction
DepreciationNonproduction
381000 USD
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
18076000 USD
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
12295000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-17512000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-11754000 USD
CY2021 us-gaap Interest Expense
InterestExpense
11386000 USD
CY2020 us-gaap Interest Expense
InterestExpense
11526000 USD
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
33000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1399000 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-12394000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-30297000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-35641000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000 USD
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-942000 USD
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2169000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-31249000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-37817000 USD
CY2021 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2737000 USD
CY2020 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33986000 USD
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-37817000 USD
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.84
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.11
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40561
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34188
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10965000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7290000 USD
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1288000 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
270000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
55000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
691000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
691000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
13214000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
8036000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78890000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53481000 USD
CY2021Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
420000 USD
CY2020Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
3000000 USD
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
976000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
1354000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
3813000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
3813000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3281000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15000 USD
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
7603000 USD
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
134000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4296000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4530000 USD
CY2021Q4 us-gaap Assets
Assets
112493000 USD
CY2020Q4 us-gaap Assets
Assets
74363000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
286000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
548000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
808000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
674000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
107000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
51000 USD
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 USD
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1847000 USD
CY2021Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
1288000 USD
CY2020Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
24000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
15000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2513000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3135000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
46477000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
78596000 USD
CY2021Q4 cdzi Lessor Operating Lease Deposit Liabilities
LessorOperatingLeaseDepositLiabilities
18855000 USD
CY2020Q4 cdzi Lessor Operating Lease Deposit Liabilities
LessorOperatingLeaseDepositLiabilities
17183000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3257000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
750000 USD
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
750000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 USD
CY2021Q4 us-gaap Liabilities
Liabilities
71884000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
99664000 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
613572000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
513744000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-573400000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-539414000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
40609000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-25301000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
112493000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
74363000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-31249000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-37817000 USD
CY2021 us-gaap Depreciation
Depreciation
423000 USD
CY2020 us-gaap Depreciation
Depreciation
381000 USD
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3475000 USD
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1062000 USD
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
15000 USD
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 USD
CY2021 cdzi Paid In Kind Interest Added To Loan Principal
PaidInKindInterestAddedToLoanPrincipal
4267000 USD
CY2020 cdzi Paid In Kind Interest Added To Loan Principal
PaidInKindInterestAddedToLoanPrincipal
7270000 USD
CY2021 cdzi Paid In Kind Interest Added To Lease Liability
PaidInKindInterestAddedToLeaseLiability
1647000 USD
CY2020 cdzi Paid In Kind Interest Added To Lease Liability
PaidInKindInterestAddedToLeaseLiability
1451000 USD
CY2021 cdzi Income Loss From Equity Method Investments Excluding Investing Activities
IncomeLossFromEquityMethodInvestmentsExcludingInvestingActivities
-942000 USD
CY2020 cdzi Income Loss From Equity Method Investments Excluding Investing Activities
IncomeLossFromEquityMethodInvestmentsExcludingInvestingActivities
-2169000 USD
CY2021 cdzi Gains Losses On Debt Conversion And Extinguishment Of Debt
GainsLossesOnDebtConversionAndExtinguishmentOfDebt
-1399000 USD
CY2020 cdzi Gains Losses On Debt Conversion And Extinguishment Of Debt
GainsLossesOnDebtConversionAndExtinguishmentOfDebt
-12394000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
4747000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2096000 USD
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-573000 USD
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-139000 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
215000 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6000 USD
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
420000 USD
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
305000 USD
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-234000 USD
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
605000 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-92000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
129000 USD
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
126000 USD
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1508000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15274000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13428000 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22908000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5729000 USD
CY2021 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
564000 USD
CY2020 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
3109000 USD
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
-0 USD
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1000000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23472000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9838000 USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
32459000 USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14767000 USD
CY2021 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
54209000 USD
CY2020 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
1449000 USD
CY2020 us-gaap Payments Of Dividends
PaymentsOfDividends
-0 USD
CY2021 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
50137000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-82118000 USD
CY2020 cdzi Adjustments To Additional Paid In Capital Reclassification Of Warrant Liability
AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantLiability
-865000 USD
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
39736000 USD
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2096000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-37817000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-25301000 USD
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000 USD
CY2020 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
150000 USD
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2878000 USD
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
-0 USD
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
77595000 USD
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
43000 USD
CY2021 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
2525000 USD
CY2020 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
-0 USD
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1184000 USD
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
-0 USD
CY2021 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
4000 USD
CY2020 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
51178000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14874000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12432000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8392000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7424000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15816000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19856000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7424000 USD
CY2021 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1184000 USD
CY2021 cdzi Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
4000 USD
CY2021 cdzi Adjustments To Additional Paid In Capital Reclassification Of Warrant Liability
AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantLiability
3179000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1795000 USD
CY2021 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
2737000 USD
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation Forfeited
StockGrantedDuringPeriodValueSharebasedCompensationForfeited
71000 USD
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4747000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-31249000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
40609000 USD
CY2021Q4 us-gaap Area Of Land
AreaOfLand
45000 acre
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-31200000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-37800000 USD
CY2021Q4 cdzi Working Capital
WorkingCapital
10700000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15300000 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-12400000 USD
CY2021Q3 cdzi Deposits Segregated Account Prefund Eight Quarterly Dividend Payments
DepositsSegregatedAccountPrefundEightQuarterlyDividendPayments
10200000 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Use of Estimates in Preparation of Financial Statements</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In preparing these financial statements, management has made estimates with regard to goodwill and other long-lived assets, stock compensation and deferred tax assets. Actual results could differ from those estimates.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3000000
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2956000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
3587000 USD
CY1988Q2 us-gaap Goodwill
Goodwill
7006000 USD
CY2020 cdzi Goodwill Amortized Portion
GoodwillAmortizedPortion
3193000 USD
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021Q4 us-gaap Goodwill
Goodwill
3800000 USD
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2300000 USD
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
800000 USD
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7487000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7064000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78890000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53481000 USD
CY2021 us-gaap Depreciation
Depreciation
423000 USD
CY2020 us-gaap Depreciation
Depreciation
381000 USD
CY2021 cdzi Interest Payments In Stock
InterestPaymentsInStock
2600000 USD
CY2021Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
1290000 USD
CY2021Q4 cdzi Accrual For Property And Equipment Received Current
AccrualForPropertyAndEquipmentReceivedCurrent
196000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10965000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7290000 USD
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1288000 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 USD
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
7603000 USD
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
134000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19856000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7424000 USD
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
10000 USD
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
7000 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
86377000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
60545000 USD
CY2021Q4 cdzi Prepaid Rent Noncurrent
PrepaidRentNoncurrent
4296000 USD
CY2020Q4 cdzi Prepaid Rent Noncurrent
PrepaidRentNoncurrent
4110000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
41000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
240000 USD
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
371000 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
104000 USD
CY2021Q4 cdzi Accrued Liabilities Related To Well Development
AccruedLiabilitiesRelatedToWellDevelopment
113000 USD
CY2020Q4 cdzi Accrued Liabilities Related To Well Development
AccruedLiabilitiesRelatedToWellDevelopment
113000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
283000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
217000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
808000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
674000 USD
CY2021Q4 us-gaap Other Loans Payable
OtherLoansPayable
171000 USD
CY2020Q4 us-gaap Other Loans Payable
OtherLoansPayable
152000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
107000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
38000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
50026000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2021Q4 cdzi Longterm Debt Maturities Repayments Of Principal In Year Five And Thereafter
LongtermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter
0 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
50171000 USD
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-573000 USD
CY2021Q2 cdzi Debt Instrument Extension Option Fee Percentage
DebtInstrumentExtensionOptionFeePercentage
0.01 pure
CY2021Q3 cdzi Deposits Segregated Account Prefund Eight Quarterly Dividend Payments
DepositsSegregatedAccountPrefundEightQuarterlyDividendPayments
10200000 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
366000 USD
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
46584000 USD
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
78647000 USD
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
107000 USD
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
51000 USD
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
46477000 USD
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
78596000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
64418000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
75303000 USD
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
4566000 USD
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
4555000 USD
CY2021Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
38000 USD
CY2020Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
32000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
1502000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
1289000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
333000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
303000 USD
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
70857000 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
81482000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
70857000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
81482000 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
10625000 USD
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
5334000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
900000 USD
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-6560000 USD
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7940000 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
492500
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.66
CY2019 cdzi Options Outstanding Balance Average Remaining Contractual Term
OptionsOutstandingBalanceAverageRemainingContractualTerm
P0Y3M18D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3834000 USD
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-8530000 USD
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3617000 USD
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43656169
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36902361
CY2013Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
400000
CY2013Q1 cdzi Percentage Of Projects Annual Capacity
PercentageOfProjectsAnnualCapacity
0.51 pure
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
1449000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
10000 USD
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
7000 USD
CY2021 cdzi Effective Income Tax Rate Reconciliation Expiring Carryforwards
EffectiveIncomeTaxRateReconciliationExpiringCarryforwards
14260000 USD
CY2020 cdzi Effective Income Tax Rate Reconciliation Expiring Carryforwards
EffectiveIncomeTaxRateReconciliationExpiringCarryforwards
1547000 USD
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
830000 USD
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
2776000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000 USD
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
377500
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
11.50
CY2020 cdzi Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited Or Expirations Aggregate Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedOrExpirationsAggregateIntrinsicValue
2915000 USD
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
115000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.17
CY2020 cdzi Options Outstanding Balance Average Remaining Contractual Term
OptionsOutstandingBalanceAverageRemainingContractualTerm
P0Y4M24D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
919000 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
115000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
12.17
CY2021 cdzi Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited Or Expirations Aggregate Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedOrExpirationsAggregateIntrinsicValue
919000 USD
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2021 cdzi Options Outstanding Balance Average Remaining Contractual Term
OptionsOutstandingBalanceAverageRemainingContractualTerm
P0Y
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y
CY2021Q2 cdzi Water Supply Agreement Number Of Acrefeet Of Water Per Annum To Customer
WaterSupplyAgreementNumberOfAcrefeetOfWaterPerAnnumToCustomer
9500 pure
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4747000 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2096000 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.31
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
-0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
149685
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
9.60
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
119281
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
9.10
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
850729
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.31
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
-0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
15312
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
10.45
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
253654
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
335763
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
10.84
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
634247
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.14
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
335000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
321000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
321000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
321000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
321000 USD
CY2021Q4 cdzi Lessee Operating Lease Liability Payments Due After Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFour
7691000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8975000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5694000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3281000 USD
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P28Y
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10 pure
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-573000 USD

Files In Submission

Name View Source Status
0001437749-22-007512-index-headers.html Edgar Link pending
0001437749-22-007512-index.html Edgar Link pending
0001437749-22-007512.txt Edgar Link pending
0001437749-22-007512-xbrl.zip Edgar Link pending
a01.jpg Edgar Link pending
cdzi-20211231.xsd Edgar Link pending
cdzi-20211231_cal.xml Edgar Link unprocessable
cdzi-20211231_def.xml Edgar Link unprocessable
cdzi-20211231_lab.xml Edgar Link unprocessable
cdzi-20211231_pre.xml Edgar Link unprocessable
cdzi20211231_10k.htm Edgar Link pending
cdzi20211231_10kimg003.jpg Edgar Link pending
cdzi20211231_10kimg004.jpg Edgar Link pending
cdzi20211231_10kimg005.jpg Edgar Link pending
cdzi20211231_10kimg006.jpg Edgar Link pending
cdzi20211231_10kimg007.jpg Edgar Link pending
cdzi20211231_10kimg008.jpg Edgar Link pending
cdzi20211231_10kimg009.jpg Edgar Link pending
cdzi20211231_10kimg010.jpg Edgar Link pending
cdzi20211231_10k_htm.xml Edgar Link completed
ex_351253.htm Edgar Link pending
ex_351471.htm Edgar Link pending
ex_351574.htm Edgar Link pending
ex_351575.htm Edgar Link pending
ex_351576.htm Edgar Link pending
ex_351577.htm Edgar Link pending
ex_351578.htm Edgar Link pending
ex_351579.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
keithb001.jpg Edgar Link pending
logo001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
picture1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending